According to a clinical study conducted at the REHAB in Basel, Switzerland, THC was effective in reducing spasticity in 25 patients with spinal cord injury. In three study phases patients received oral THC, rectal THC-hemisuccinate (THC-HS) and/or placebo, each for six weeks. Originally, it was planned to start with an open phase with oral THC followed by an open phase with rectal THC-HS and then a three-way crossover placebo-controlled phase with oral THC and rectal THC-HS. Due to logistical problems with the import of THC- HS Phase 2 had to be stopped after inclusion of seven patients. Phase 3 was changed to a parallel study with oral THC and placebo.
Διαβάστε περισσότερα …

BRYAN – Shonnie Moore of College Station, paralyzed in a July 2005 traffic accident, has had to learn how to eat, bathe and live all over again through physical therapy.
Διαβάστε περισσότερα …

Pasadena, CA (PRWEB) — The illumination of the human genome has opened the door to a vast range of medical therapies. The promise of drugs and interventions tuned to the individual patient’s genetics holds persuasive advantage over the one-size-fits-all generic remedies we count on today. Further progress in this booming field of molecular medicine, however, relies in part on continuing stem cell research using human embryos. Although the cells themselves are microscopic, their use in medical research has become one of the biggest current moral issues in society.
Διαβάστε περισσότερα …